SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-22-183411
Filing Date
2022-06-28
Accepted
2022-06-28 08:32:54
Documents
1
Group Members
PABLO G. LEGORRETAROYALTY PHARMA INVESTMENTS 2019 ICAVRP MANAGEMENT, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d267685dsc13da.htm SC 13D/A 86908
  Complete submission text file 0001193125-22-183411.txt   88544
Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Subject) CIK: 0001571498 (see all company filings)

IRS No.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87481 | Film No.: 221046610
SIC: 2834 Pharmaceutical Preparations

Mailing Address 110 EAST 59TH STREET SUITE 3300 NEW YORK NY 10022
Business Address 110 EAST 59TH STREET SUITE 3300 NEW YORK NY 10022 212-883-0200
RPI Finance Trust (Filed by) CIK: 0001793690 (see all company filings)

IRS No.: 456358481 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A